Počet záznamů: 1  

Pharmacological caspase inhibitors: Research towards therapeutic perspectives

  1. 1.
    0473501 - ÚIACH 2017 RIV PL eng J - Článek v odborném periodiku
    Kudělová, J. - Fleischmannová, J. - Adamová, E. - Matalová, Eva
    Pharmacological caspase inhibitors: Research towards therapeutic perspectives.
    Journal of Physiology and Pharmacology. Roč. 66, č. 4 (2015), s. 473-482. ISSN 0867-5910
    Grant CEP: GA ČR(CZ) GA14-28254S
    Institucionální podpora: RVO:68081715
    Klíčová slova: caspase * caspase inhibitor * apoptosis
    Kód oboru RIV: CB - Analytická chemie, separace
    Impakt faktor: 2.804, rok: 2015

    Caspases are key molecules of apoptosis and the inflammatory response. Up-regulation of the caspase cascade contributes to human pathologies such as neurodegenerative and immune disorders. Thus, blocking the excessive apoptosis by pharmacological inhibitors seems promising for therapeutic interventions in such diseases. Caspase inhibitors, both natural and artificial, have been used as research tools and have helped to define the role of the individual caspases in apoptosis and in non-apoptotic processes. Moreover, some caspase inhibitors have demonstrated their therapeutic efficiency in the reduction of cell death and inflammation in animal models of human diseases. However, no drug based on caspase inhibition has been approved on the market until now. Thus, the development of therapeutic approaches that specifically target caspases remains a great challenge and is now the focus of intense biological and clinical interest. Here, we provide a brief review of recent knowledge about pharmacological caspase inhibitors with special focus on their proposed clinical applications.
    Trvalý link: http://hdl.handle.net/11104/0270615

     
    Název souboruStaženoVelikostKomentářVerzePřístup
    0473501.pdf3302.1 KBAutorský postprintvyžádat
     
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.